Abstract:PURPOSE: Split thickness skin graft (STSG) implantation is one of the standard therapies for full thickness wound repair when autologous skin full thickness graft (FTG) or skin flap transplants are inapplicable. However, STSG are more fragile than FTG and can contract significantly during the healing process. Human mesenchymal stem cells (hMSCs) are capable of accelerating the wound healing process. So we use pre-vascularized hMSC sheets (PHCS) to study if they would further improve the repair quality of STSG. METHODS:In vitro cultured control hMSC cell sheets (HCS) were obtained after four weeks culture in complete culture medium (CCM), then endothelial cells (ECs) were cocultured on top of the hMSC sheets for 1 week to get PHCS. Immunofluorescence staining was used to characterize both cell sheets. The progenitor population and multi-lineage differentiation ability of hMSCs inside the cell sheets were tested. The angiogenic growth factor amount present in the cell sheets was also analyzed using an enzyme-linked immunosorbent assay (ELISA). The cell sheets were applied in combination with an autologous STSG in rats with full thickness skin wound. Graft survival and contraction was evaluated and the implants were harvested at predetermined time points for analysis (n=6 animals per group). Histology and immunohistochemistry were performed to test if PHCS can enhance the therapeutic effects of STSG. RESULTS: The hMSCs in HCS still maintain self-renewal and differentiation capacity after extended periods of culture. The TGF-β1, ANG1 and ANG2 amount in PHCS was higher than HCS (p<0.05) whereas the VEGF amount in PHCS was significantly lower than that in HCS (p<0.05). The HCS and the PHCS implantation significantly reduced skin contraction and improved cosmetic appearance relative to the STSG control group. The PHCS group experienced the least hemorrhage and necrosis, and lowest inflammatory cell infiltration. It also induced the highest neovascularization in early stages, which established a robust blood micro-circulation to support grafts survival and tissue regeneration. Moreover, the PHCS grafts preserved the largest amount of skin appendages (including hair follicles and sebaceous glands) and developed the smallest epidermal thickness. The collagen deposition and fibril morphology in PHCS grafts were also similar to normal skin, indicating a lower degree of skin fibrosis. The superior therapeutic effect seen in PHCS groups was attributed to the elevated presence of growth factors and cytokines in the pre-vascularized cell sheet, which exerted a beneficial paracrine signaling during the early stage of wound repair. CONCLUSION: The strategy of combining autologous STSG with PHCS implantation appears to be a promising approach in regenerative treatment of full thickness skin wounds.

Multi-faceted enhancement of full-thickness skin wound healing by treatment with autologous micro skin tissue columns

956 Epidermal Autophagy Deficiency Impairs Skin Wound Healing Through Inhibiting Keratinocyte Proliferation and Migration and Fibroblast Activation

Abstract P21: Enhancement of Therapeutic Benefits of Split Thickness Skin Grafts Using Pre-vascularized Human Mesenchymal Stem Cells

The Progress and Challenges for Dermal Regeneration in Tissue Engineering.

Pre-vascularization Enhances Therapeutic Effects of Human Mesenchymal Stem Cell Sheets in Full Thickness Skin Wound Repair

Enhanced Wound Healing and Autogenesis Through Lentiviral Transfection of Adipose-Derived Stem Cells Combined with Dermal Substitute

80 Donor Skin Reduction in Full-thickness Wounds Using Autologous Cell Harvesting Device with Meshed Autograft

Autologous micrograft accelerates endogenous wound healing response through ERK-induced cell migration

Mesenchymal Stromal Cells and Cutaneous Wound Healing: A Comprehensive Review of the Background, Role, and Therapeutic Potential

Application of a minimally invasive full‐thickness autologous microcolumn skin harvesting device for donor site tissue collection and augmenting wound healing in a porcine wound model

A novel method for the establishment of autologous skin cell suspensions: characterisation of cellular sub-populations, epidermal stem cell content and wound response-enhancing biological properties

In Situ Bioprinting of Autologous Skin Cells Accelerates Wound Healing of Extensive Excisional Full-Thickness Wounds

Long-term experience with a collagen-elastin scaffold in combination with split-thickness skin grafts for the treatment of full-thickness soft tissue defects: improvements in outcome—a retrospective cohort study and case report

Efficacy of autologous micrografts technology: a promising approach for chronic wound healing and tissue regeneration—a pilot study

Accelerated epithelialization and improved wound healing metrics in porcine full-thickness wounds transplanted with full-thickness skin micrografts

Benefits of Aerosolized, Point-of-care, Autologous Skin Cell Suspension (ASCS) for the Closure of full Thickness Wounds from Thermal and Non-Thermal Causes

Comparative Analysis of Autologous Skin Cell-suspension Technology and Split-thickness Skin Grafting for Subacute Wounds in Medically Complex Patients: Propensity-Matched Cohort Study

Advances in Mesenchymal Stem Cell Therapy for Cutaneous Wounds

Evaluation in a porcine wound model and long-term clinical assessment of an autologous heterogeneous skin construct used to close full-thickness wounds

Second-harmonic generation microscopy for assessment of mesenchymal stem cell-seeded acellular dermal matrix in wound-healing.

Clinical Translational Potential in Skin Wound Regeneration for Adipose-Derived, Blood-Derived, and Cellulose Materials: Cells, Exosomes, and Hydrogels